| Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer A Vaishnavi, M Capelletti, AT Le, S Kako, M Butaney, D Ercan, S Mahale, ... Nature medicine 19 (11), 1469-1472, 2013 | 686 | 2013 |
| The TAM family: phosphatidylserine-sensing receptor tyrosine kinases gone awry in cancer DK Graham, D DeRyckere, KD Davies, HS Earp Nature Reviews Cancer 14 (12), 769-785, 2014 | 670 | 2014 |
| Identifying and targeting ROS1 gene fusions in non–small cell lung cancer KD Davies, AT Le, MF Theodoro, MC Skokan, DL Aisner, EM Berge, ... Clinical Cancer Research 18 (17), 4570-4579, 2012 | 524 | 2012 |
| Molecular pathways: ROS1 fusion proteins in cancer KD Davies, RC Doebele Clinical cancer research 19 (15), 4040-4045, 2013 | 404 | 2013 |
| Phospho-regulation of synaptic and extrasynaptic N-methyl-d-aspartate receptors in adult hippocampal slices SM Goebel-Goody, KD Davies, RMA Linger, RK Freund, MD Browning Neuroscience 158 (4), 1446-1459, 2009 | 219 | 2009 |
| Resistance Mechanisms to Targeted Therapies in ROS1+ and ALK+ Non–small Cell Lung Cancer CE McCoach, AT Le, K Gowan, K Jones, L Schubert, A Doak, ... Clinical Cancer Research 24 (14), 3334-3347, 2018 | 217 | 2018 |
| Dual mechanism of a natural CaMKII inhibitor RS Vest, KD Davies, H O'Leary, JD Port, KU Bayer Molecular biology of the cell 18 (12), 5024-5033, 2007 | 208 | 2007 |
| Autophagy inhibition overcomes multiple mechanisms of resistance to BRAF inhibition in brain tumors JM Mulcahy Levy, S Zahedi, AM Griesinger, A Morin, KD Davies, ... Elife 6, e19671, 2017 | 174 | 2017 |
| Resistance to ROS1 inhibition mediated by EGFR pathway activation in non-small cell lung cancer KD Davies, S Mahale, DP Astling, DL Aisner, AT Le, TK Hinz, A Vaishnavi, ... PloS one 8 (12), e82236, 2013 | 162 | 2013 |
| Tumor-infiltrating T cells and the PD-1 checkpoint pathway in advanced differentiated and anaplastic thyroid cancer JJ Bastman, HS Serracino, Y Zhu, MR Koenig, V Mateescu, SB Sams, ... The Journal of Clinical Endocrinology & Metabolism 101 (7), 2863-2873, 2016 | 160 | 2016 |
| Clinical utility of cell-free DNA for the detection of ALK fusions and genomic mechanisms of ALK inhibitor resistance in non–small cell lung cancer CE McCoach, CM Blakely, KC Banks, B Levy, BM Chue, VM Raymond, ... Clinical Cancer Research 24 (12), 2758-2770, 2018 | 158 | 2018 |
| Comparison of molecular testing modalities for detection of ROS1 rearrangements in a cohort of positive patient samples KD Davies, AT Le, J Sheren, H Nijmeh, K Gowan, KL Jones, ... Journal of Thoracic Oncology 13 (10), 1474-1482, 2018 | 150 | 2018 |
| DNA-based versus RNA-based detection of MET exon 14 skipping events in lung cancer KD Davies, A Lomboy, CA Lawrence, M Yourshaw, GT Bocsi, ... Journal of Thoracic Oncology 14 (4), 737-741, 2019 | 124 | 2019 |
| Radiation induces acute alterations in neuronal function PH Wu, S Coultrap, C Pinnix, KD Davies, R Tailor, KK Ang, MD Browning, ... PloS one 7 (5), e37677, 2012 | 115 | 2012 |
| Chk1 inhibition and Wee1 inhibition combine synergistically to impede cellular proliferation KD Davies, PLA Cable, JE Garrus, FX Sullivan, I von Carlowitz, ... Cancer biology & therapy 12 (9), 788-796, 2011 | 95 | 2011 |
| EGFR mediates responses to small-molecule drugs targeting oncogenic fusion kinases A Vaishnavi, L Schubert, U Rix, LA Marek, AT Le, SB Keysar, ... Cancer research 77 (13), 3551-3563, 2017 | 77 | 2017 |
| MET exon 14 skipping mutations in non–small-cell lung cancer: an overview of biology, clinical outcomes, and testing considerations MA Socinski, NA Pennell, KD Davies JCO precision oncology 5, 2021 | 75 | 2021 |
| Final report of a phase I trial of olaparib with cetuximab and radiation for heavy smoker patients with locally advanced head and neck cancer SD Karam, K Reddy, PJ Blatchford, T Waxweiler, AM DeLouize, A Oweida, ... Clinical Cancer Research 24 (20), 4949-4959, 2018 | 75 | 2018 |
| Dramatic response to crizotinib in a patient with lung cancer positive for an HLA-DRB1-MET gene fusion KD Davies, TL Ng, A Estrada-Bernal, AT Le, PR Ennever, DR Camidge, ... JCO precision oncology 1, 2017 | 72 | 2017 |
| Validation of a targeted RNA sequencing assay for kinase fusion detection in solid tumors JW Reeser, D Martin, J Miya, EA Kautto, E Lyon, E Zhu, MR Wing, A Smith, ... The Journal of Molecular Diagnostics 19 (5), 682-696, 2017 | 64 | 2017 |
